EFfCI»¯×±Æ·ÔÁÏÈÏÖ¤»ñÖ¤×éÖ¯ÓÐÒÔÏÂÇéÐÎÖ®Ò»µÄ£¬EFfCIÈÏÖ¤Ó¦ÔÚ»ñµÃÏà¹ØÐÅÏ¢²¢µ÷²éºËʵºó 5¸ö¹¤×÷ÈÕÄÚ³·ÏúÆäÈÏÖ¤Ö¤Êé¡££¨1£©±»×¢Ïú»ò³·Ïú·¨ÂɵØÎ»Ö¤Ã÷ÎļþµÄ¡££¨2£©¾Ü¾øÅäºÏÈÏÖ¤¼à¹Ü²¿ÃÅʵʩµÄ¼à¶½¼ì²é£¬»òÕß¶ÔÓйØÊÂÏîµÄѯÎʺ͵÷²éÌṩÁËÐé¼Ù²ÄÁÏ»òÐÅÏ¢µÄ¡££¨3£©³öÏÖÖØ´óµÄyingyaÓ¢ÑÇÌåÓýƽ̨ʹʣ¬¾Ö´·¨¼à¹Ü²¿ÃÅÈ·ÈÏÊÇ»ñÖ¤×é֯Υ¹æÔì³ÉµÄ¡££¨4£©ÓÐÆäËûÑÏÖØÎ¥·´·¨ÂÉ·¨¹æÐÐΪµÄ¡££¨5£©ÔÝÍ£ÈÏÖ¤Ö¤ÊéµÄÆÚÏÞÒÑÂúµ«µ¼ÖÂÔÝÍ£µÄÎÊÌâδµÃµ½½â¾ö»ò¾ÀÕýµÄ£¨°üÀ¨³ÖÓеÄÐÐÕþÐí¿ÉÖ¤Ã÷¡¢×ÊÖÊÖ¤Êé¡¢Ç¿ÖÆÐÔÈÏÖ¤Ö¤ÊéµÈÒѾ¹ýÆÚʧЧµ«ÉêÇëδ»ñÅú×¼£©¡££¨6£©Ã»ÓÐÔËÐйÜÀíÌåϵ»òÕßÒѲ»¾ß±¸ÔËÐÐÌõ¼þµÄ¡££¨7£©²»°´Ïà¹Ø¹æ¶¨ÕýÈ·ÒýÓúÍÐû´«»ñµÃµÄÈÏÖ¤ÐÅÏ¢£¬Ôì³ÉÑÏÖØÓ°Ïì»òºó¹û£¬»òÕßEFfCIÈÏÖ¤ÒÑÒªÇóÆä¾ÀÕýµ«³¬¹ý 6 ¸öÔÂÈÔδ¾ÀÕýµÄ¡££¨8£©ÆäËûÓ¦µ±³·ÏúÈÏÖ¤Ö¤ÊéµÄ¡£³·ÏúÈÏÖ¤Ö¤Êéºó£¬EFfCIÈÏÖ¤Ó¦¼°Ê±Êջس·ÏúµÄÈÏÖ¤Ö¤Êé¡£²¢ÔÚEFfCIÈÏÖ¤ÍøÕ¾ÉϹ«²¼»òÉùÃ÷³·Ïú¾ö¶¨¡£EFfCIÈÏÖ¤ÔÝÍ£¼°³·ÏúÈÏÖ¤Ö¤ÊéµÄÏûÏ¢½«°´¹æ¶¨³ÌÐòºÍÒªÇ󱨹ú¼ÒÈϼàί¡£
·¢²¼Ê±¼ä:
2019
-
04
-
29
ä¯ÀÀ´ÎÊý£º259
EFfCI»¯×±Æ·ÔÁÏÈÏÖ¤»ñÖ¤×éÖ¯ÓÐÒÔÏÂÇéÐÎÖ®Ò»µÄ£¬¾µ÷²éºËʵ£¬ÔÚ 5 ¸ö¹¤×÷ÈÕÄÚÔÝÍ£ÆäÈÏÖ¤Ö¤Êé¡££¨1£©EFfCI ¹ÜÀíÌåϵ³ÖÐø»òÑÏÖØ²»Âú×ãÈÏÖ¤ÒªÇ󣬰üÀ¨¶Ô EFfCI ¹ÜÀíÌåϵÔËÐÐÓÐЧÐÔÒªÇóµÄ¡££¨2£©²»³Ðµ¡ñ£¡¢ÂÄÐÐÈÏÖ¤ºÏͬԼ¶¨µÄÔðÈκÍÒåÎñµÄ¡££¨3£©±»ÓйØÖ´·¨¼à¹Ü²¿ÃÅÔðÁîÍ£ÒµÕû¶ÙµÄ¡££¨4£©±»µØ·½ÈÏÖ¤¼à¹Ü²¿ÃÅ·¢ÏÖÌåϵÔËÐдæÔÚÎÊÌ⣬ÐèÒªÔÝÍ£Ö¤ÊéµÄ¡££¨5£©³ÖÓеÄÐÐÕþÐí¿ÉÖ¤Ã÷¡¢×ÊÖÊÖ¤Êé¡¢Ç¿ÖÆÐÔÈÏÖ¤Ö¤ÊéµÈ¹ýÆÚʧЧ£¬ÖØÐÂÌá½»µÄÉêÇëÒѱ»ÊÜÀíµ«ÉÐδ»»Ö¤µÄ¡££¨6£©Ã»Óа´ÕÕÒªÇó¼°Ê±½ÓÊܼලÉóºË¡££¨7£©Ö÷¶¯ÇëÇóÔÝÍ£µÄ¡££¨8£©ÆäËûÓ¦µ±ÔÝÍ£ÈÏÖ¤Ö¤ÊéµÄÖ¤ÊéµÄÔÝÍ£ÆÚÏÞ 3 ¸öÔ£¬ÔÚÔÝÍ£ÆÚ¼ä¿Í»§²»ÄÜʹÓÃÈÏÖ¤Ö¤Êé½øÐÐ¹ã¸æºÍÐû´«»î¶¯¡£EFfCIÈÏÖ¤½«ÔÚ¹«Ë¾ÍøÕ¾ÉϹ«²¼ÔÝÍ£¾ö¶¨¡£
·¢²¼Ê±¼ä:
2019
-
04
-
29
ä¯ÀÀ´ÎÊý£º240
1¡¢EFfCI»¯×±Æ·ÔÁÏÈÏÖ¤Ö¤ÊéÓ¦ÖÁÉÙ°üº¬ÒÔÏÂÐÅÏ¢£º1£©»ñÖ¤×éÖ¯Ãû³ÆºÍµØÖ·¡£2£©Ìåϵ¸²¸ÇµÄÉú²ú¾Óª»ò·þÎñµÄÒµÎñ·¶Î§¡£3£©Ìåϵ·ûºÏ¡¶EFfCI ±ê×¼¡·±íÊö¡£4£©EFfCIÈÏÖ¤Ö¤Êé±àºÅ¡£5£©EFfCIÈÏÖ¤Ãû³Æ¡£6£©Ö¤ÊéÇ©·¢ÈÕÆÚ¼°ÓÐЧÆÚµÄÆðÖ¹ÄêÔÂÈÕ¡£2¡¢ ÈÏÖ¤Ö¤ÊéÓÐЧÆÚΪÈýÄê¡£3¡¢ EFfCIÈÏÖ¤ÔÚ°ä·¢ÈÏÖ¤Ö¤Êéºó£¬½«°´Õչ涨µÄÒªÇó½«Ïà¹ØÐÅÏ¢±¨Ë͹ú¼ÒÈϼàί¡£EFfCIÈÏÖ¤²»½«ÉêÇë×éÖ¯ÊÇ·ñ»ñµÃÈÏÖ¤Óë²ÎÓëÈÏÖ¤ÉóºËµÄÉóºËÔ±¼°ÆäËûÈËÔ±µÄн³ê¹Ò¹³¡£
·¢²¼Ê±¼ä:
2019
-
04
-
26
ä¯ÀÀ´ÎÊý£º265
EFfCI»¯×±Æ·ÔÁÏÈÏÖ¤µÄÉóºË¼Æ»®ÈçÏ£º1¡¢ÉóºË¼Æ»®EFfCIÈÏÖ¤½«ÊéÃæÍ¨ÖªÉóºË×éʵʩÉóºË£¬ÖÁÉÙ°üÀ¨ÒÔÏÂÄÚÈÝ£ºÉóºËÄ¿µÄ¡¢ÉóºË·¶Î§¡¢ÉóºËÉæ¼°µÄ³¡Ëù¡¢ÉóºËʱ¼ä¡¢ÉóºË×é³ÉÔ±¡£Í¨³£Çé¿öÏ£¬³õ´ÎÈÏÖ¤ÉóºË½«ÔÚÉêÇë×éÖ¯ÉêÇëÈÏÖ¤µÄ·¶Î§Éæ¼°µ½µÄ¸÷¸ö³¡ËùÏÖ³¡½øÐС£ÎªÊ¹ÏÖ³¡ÉóºË»î¶¯Äܹ»¹Û²ìµ½yingyaÓ¢ÑÇÌåÓýƽ̨Éú²ú»ò·þÎñ»î¶¯Çé¿ö£¬ÏÖ³¡ÉóºË½«°²ÅÅÔÚÈÏÖ¤·¶Î§¸²¸ÇµÄyingyaÓ¢ÑÇÌåÓýƽ̨Éú²ú»ò·þÎñ»î¶¯Õý³£ÔËÐÐʱ½øÐС£ÔÚÉóºË»î¶¯¿ªÊ¼Ç°£¬ÉóºË×齫ÊéÃæÉóºË¼Æ»®½»ÉêÇë×é֯ȷÈÏ¡£ÓöÌØÊâÇé¿öÁÙʱ±ä¸ü¼Æ»®Ê±£¬»á¼°Ê±½«±ä¸üÇé¿öÊéÃæÍ¨ÖªÊÜÉóºËµÄÉêÇë×éÖ¯£¬²¢ÐÉÌÒ»Ö¡£ 2¡¢ÊµÊ©ÉóºËÉóºË×齫ȫԱÍê³ÉÉóºË¼Æ»®µÄÈ«²¿¹¤×÷¡£³ý²»¿ÉÔ¤¼ûµÄÌØÊâÇé¿öÍ⣬ÉóºË¹ý³ÌÖв»»á¸ü»»ÉóºË¼Æ»®È·¶¨µÄÉóºËÔ±£¨¼¼Êõר¼ÒºÍʵϰÉóºËÔ±³ýÍ⣩¡£ÉóºË×齫»áͬÉêÇë×éÖ¯°´ÕÕÉóºË¼Æ»®ÕÙ¿ªÊס¢Ä©´Î»áÒé¡£ÏÖ³¡ÉóºËÏÖ³¡ÉóºË°üÀ¨ÒÔÏÂÆß¸ö½×¶Î£ºa)Ê״λáÒ顪¡ªÈ·ÈÏÉóºË·¶Î§ºÍÁ÷³Ì¡£b)Éú²úÉèÊ©ÉóºË¡ª¡ªÉóºËÌåϵµÄʵ¼ÊʵʩÇé¿ö£¬°üÀ¨¹Û²ìyingyaÓ¢ÑÇÌåÓýƽ̨ת»»¹æ³ÌºÍÈËÔ±·Ã̸¡£c)ÎļþÉóºË¡ª¡ªÉóÔÄÖÊÁ¿¹ÜÀíÌåϵÎļþ¡£d)³ÉÆ·ÉóºËºÍ¹æ¸ñ¡£e)Éú²úÉèÊ©ÉóºË¡ª¡ªÑéÖ¤¼°½øÒ»²½ÉóºËÎļþ¡£f)ÉóºËÔ±¶ÔÉóºË·¢ÏÖµÄ×îÖջعˡª¡ªÎª×ܽá»á×ö×¼±¸¡£g)×ܽá»á¡ª¡ªÓëÉêÇë×éÖ¯Ò»Æð»Ø¹ËÉóºË·¢ÏÖ¡£3¡¢ ²»·ûºÏÏîÉóºËÔ±ÒÀÕÕ±¾EFfCI±ê×¼µÄÒªÇóËùÆÀ¶¨µÄ²»·ûºÏÏî¼¶±ðÊÇÒÀÕÕÉóºËÆÚ¼äËùÊÕ¼¯µÄÖ¤¾ÝÒÔ¼°Ëù½øÐеĹ۲죬¶Ô²»·ûºÏÏîµÄÑÏÖØÐԺͷçÏÕ×÷³öµÄ¿Í¹ÛÅжϡ£¶ÔÉóºËÖÐ...
·¢²¼Ê±¼ä:
2019
-
04
-
26
ä¯ÀÀ´ÎÊý£º367
EFfCI»¯×±Æ·ÔÁÏÈÏÖ¤ÒªÇóÉêÇë×éÖ¯Ìá½»ÒÔÏÂ×ÊÁÏ£º£¨1£©ÈÏÖ¤ÉêÇëÊ飬°üÀ¨ÉêÇë×éÖ¯µÄÉú²ú¾Óª»ò·þÎñ»î¶¯µÈÇé¿öµÄ˵Ã÷¡££¨2£©·¨ÂɵØÎ»µÄÖ¤Ã÷Îļþ£¨°üÀ¨£ºÆóÒµÓªÒµÖ´ÕÕ¡¢Ë°ÎñµÇ¼ÇÖ¤µÈ£©µÄ¸´Ó¡¼þ¡£ÈôÌåϵ¸²¸Ç¶àÉú²úÏÖ³¡»î¶¯£¬Ó¦¸½Ã¿¸öÉú²úÏÖ³¡µÄ·¨ÂɵØÎ»Ö¤Ã÷ÎļþµÄ¸´Ó¡¼þ¡££¨3£©×éÖ¯»ú¹¹´úÂëÖ¤ÊéµÄ¸´Ó¡¼þ¡££¨4£©¹ÜÀíÌåϵ¸²¸ÇµÄ»î¶¯ËùÉæ¼°·¨ÂÉ·¨¹æÒªÇóµÄÐÐÕþÐí¿ÉÖ¤Ã÷¡¢×ÊÖÊÖ¤ÊéµÈµÄ¸´Ó¡¼þ¡££¨5£©Íⲿ֧³Ö³¡Ëù»î¶¯¡¢»î¶¯·Ö°üÇé¿ö¡£ £¨6£©ÆäËûÓëÈÏÖ¤ÉóºËÓйصıØÒªÎļþ¡£ ¸ù¾ÝÉêÇë×éÖ¯ÉêÇëµÄÈÏÖ¤·¶Î§¡¢Éú²ú¾Óª³¡Ëù¡¢Ô±¹¤ÈËÊý¡¢Íê³ÉÉóºËËùÐèʱ¼äºÍÆäËûÓ°ÏìÈÏÖ¤»î¶¯µÄÒòËØ£¬×ÛºÏÈ·¶¨ÊÇ·ñÓÐÄÜÁ¦ÊÜÀíÈÏÖ¤ÉêÇë¡£¶Ô·ûºÏÒªÇóµÄ£¬EFfCIÈÏÖ¤¿É¾ö¶¨ÊÜÀíÈÏÖ¤ÉêÇ룻¶Ô²»·ûºÏÒªÇóµÄ£¬EFfCIÈÏÖ¤½«Í¨ÖªÉêÇë×éÖ¯²¹³äºÍÍêÉÆ£¬»òÕß²»ÊÜÀíÈÏÖ¤ÉêÇë¡£EFfCIÈÏÖ¤½«ÍêÕû±£´æÈÏÖ¤ÉêÇëµÄÉó²éÈ·ÈϹ¤×÷¼Ç¼¡£Ç©¶©ÈÏÖ¤ºÏͬÔÚʵʩÈÏÖ¤ÉóºËǰ£¬EFfCIÈÏÖ¤½«ÓëÉêÇë×éÖ¯¶©Á¢¾ßÓз¨ÂÉЧÁ¦µÄÊéÃæÈÏÖ¤ºÏͬ¡£
·¢²¼Ê±¼ä:
2019
-
04
-
26
ä¯ÀÀ´ÎÊý£º265
EFfCI GMP AUDIT CHECKLIST FOR COSMETIC INGREDIENTS 4 CONTEXT OF THE ORGANISATION×éÖ¯µÄ»·¾³4.1 Understanding the Organisation and its context×éÖ¯¼°×éÖ¯»·¾³µÄÀí½âAre external and internal issues concerning Cosmetic Ingredients (CI) Identified?ÊÇ·ñÒÑʶ±ð×éÖ¯ÄÚÍⲿÓйØÓÚ»¯×±Æ·³É·ÖµÄÊÂÏAre these reflected in the organization of QMS and GMP?ÕâЩ»·¾³ÒòËØÊÇ·ñÔÚʵʩQMSºÍGMPʱÌåÏÖ£¿Are issues reviewed and in particular is relevant legislation monitored for changes that may affect CI?ÊÇ·ñ¶Ô¿ÉÄÜÓ°Ï컯ѧƷ³É·ÖµÄÏà¹Ø¼à¶½·¨¹æ½øÐÐÆÀÉó£¿4.2 Understanding the needs and expectations of interested PartiesÁ˽âÀûÒæÏà¹Ø·½µÄÐèÇóºÍÆÚÍûAre interested parties and their requirements ide...
·¢²¼Ê±¼ä:
2018
-
10
-
16
ä¯ÀÀ´ÎÊý£º595
Ŀ¼1.ÊÊÓ÷¶Î§2.¶ÔÈÏÖ¤ÈËÔ±µÄÒªÇó3.³õ´ÎÈÏÖ¤³ÌÐò4.¼à¶½ÉóºË5.ÔÙÈÏÖ¤6.ÔÝÍ£»ò³·ÏúÈÏÖ¤Ö¤Êé7.ÈÏÖ¤Ö¤ÊéÒªÇó8.ÊÜÀí×éÖ¯µÄÉêËß9.ÈÏÖ¤¼Ç¼µÄ¹ÜÀí1.2±¾¹æÔòÊǶԱØÎ¬ÈÏÖ¤´ÓÊ EFfCI ¹æ·¶ÈÏÖ¤»î¶¯µÄ»ù±¾ÒªÇ󣬱ØÎ¬ÈÏÖ¤´ÓÊÂEFfCI ÈÏÖ¤»î¶¯Ðè×ñÊØ±¾¹æÔò¡£2 ¶ÔÈÏÖ¤ÈËÔ±µÄÒªÇó2.1ÉóºËÈËÔ±Ðèͨ¹ý EFfCI ÉóºËÔ±Åàѵ£¬²¢È¡µÃ±ØÎ¬ÈÏÖ¤ EFfCI ÉóºËÔ±×ʸñ¡£2.2ÆäËûÈËÔ±ÈçÉêÇëÆÀÉóÈËÔ±¡¢ÉóºË¼Æ»®ÅųÌÈËÔ±¡¢ÈÏÖ¤¾ö¶¨ÈËÔ±µÈ£¬Ó¦¾ÆÀ¼ÛÈ·ÈÏÂú×ã±ØÎ¬ÈÏ֤ȷ¶¨ÄÜÁ¦ÒªÇó¡£2.2 ÈÏÖ¤ÈËÔ±½«×ñÊØÓë´ÓÒµÏà¹ØµÄ·¨ÂÉ·¨¹æºÍÈÏÖ¤¹æÔò£¬¶ÔÈÏÖ¤»î¶¯¼°×÷³öµÄÈÏÖ¤ÉóºË±¨¸æºÍÈÏÖ¤½áÂÛµÄÕæÊµÐԳе£ÏàÓ¦µÄ·¨ÂÉÔðÈÎ
·¢²¼Ê±¼ä:
2018
-
10
-
16
ä¯ÀÀ´ÎÊý£º318
»¯×±Æ·ÔÁϵÄÖÊÁ¿¶ÔÓÚ±£Ö¤»¯×±Æ·ºÍÏà¹ØµÄ¸öÈË·À»¤ÓÃÆ·µÄ°²È«¡¢ÖÊÁ¿ºÍ¹¦Ð§ÊÇÖÁ¹ØÖØÒªµÄ¡£»¯×±Æ·ÔÁÏÓÐ×Å·¶Î§¹ã·ºµÄÓÃ;£¬ÊÇ»¯×±Æ·Åä·½µÄÖ÷Òª³É·Ý¡£Òò´Ë£¬Ó¦Óû¯×±Æ·ÔÁÏÊÊÓõÄÁ¼ºÃ²Ù×÷¹æ·¶£¨GMP£©ÊDZز»¿ÉÉٵġ£EFfCI£¨European Federation for Cosmetic Ingredients£©ÊÇÅ·ÖÞ»¯Ñ§ºÍÌìÈ»ÔÁÏÐÐҵлáµÄÓ¢Îļò³Æ£¬ÊÇÅ·ÖÞ»¯×±Æ·ÐÐÒµµÄ¹©Ó¦É̺ͷþÎñÌṩÉÌÁªÃË¡£EFfCIÓÚ2000Äê³ÉÁ¢£¬´ú±íÁËÅ·ÖÞ³¬¹ý100¼Ò»¯×±Æ·ÔÁϹ«Ë¾µÄ¼¯ÌåÀûÒæ¡£Æä³ÉÔ±°üÀ¨BASF¡¢BIOCHIM¡¢CRODA¡¢GATTEFOSSE¡¢RES PHARMA INDUSTRIALE¡¢SABO¡¢VEVY EUROPEµÈÅ·ÖÞ¸÷¹úÖªÃû»¯×±Æ·ÔÁÏÉÌ¡£EFfCI»¯×±Æ·ÔÁÏGMP£¬ÊÇÓÉEFfCI·¢²¼µÄÈÏÖ¤±ê×¼£¬Æä¸ù±¾ÀíÄÊÇΪ»¯×±Æ·ÔÁÏÖÆÔìÉÌÌṩһ¸ö¸üºÏÊʵġ¢ÓбðÓÚ»¯×±Æ·µÄ¡¢¾ßÓпɲÙ×÷ÐÔµÄGMPÖ´Ðй¤¾ß¡£EFfCI·Ç³£ÖØÊÓ×îÐÂÆÀÂÛ£¬ÒÔ×÷ΪEFfCI GMPÖ¸ÄϽøÒ»²½·¢Õ¹µÄÊäÈë¡£×Ô2005Äê³É¹¦ÍÆÐС¢2008Äê¸üÐÂÈÏÖ¤¼Æ»®ºÍ±ê×¼ÒÔÀ´£¬EFfCI:2012 GMPÊÇÓ¡Ë¢·¢ÐеĵÚÈý°æ±ê×¼£¬ÍêÈ«ÕûºÏÁËISO9001:2008±ê×¼µÄÄÚÈÝ£¬ÔÚÈ·±£·´Ó³ISO9001±ê×¼×îа汾ÄÚÈݵÄͬʱ£¬»¹²Î¿¼ÁËÒ©Æ·ºÍʳƷGMPÒªÇ󣬼ÓÈëÁËÖÊÁ¿·çÏÕ¹ÜÀí·½·¨£¬ÒÔ°ïÖú»¯Ñ§ºÏ³ÉºÍÏà¹ØÖÆÔì¹ý³ÌÖ´ÐÐÊʵ±µÄGMPÔÔò¡£Ð°æ±ê×¼ÖÐÐÂÔöµÄ¸½¼þ£¬³ÂÊöÁËÒѾ...
·¢²¼Ê±¼ä:
2017
-
04
-
19
ä¯ÀÀ´ÎÊý£º668
Ô±¹¤ÓÐЧÈËÊýÓëÉóºËʱ¼äµÄ¹ØÏµ£¨½öÊÊÓÃÓÚ³õ´ÎÉóºË£© ÉóºËʱ¼äÉóºËʱ¼äÓÐЧÈËÊýµÚ 1 ½×¶Î£«µÚ 2 ½×¶ÎÓÐЧÈËÊýµÚ 1 ½×¶Î£«µÚ 2 ½×¶Î£¨Ì죩£¨Ì죩1-51.5626-875126-102876-11751311-152.51176-15501416-2531551-20251526-4542026-26751646-6552676-34501766-8563451-43501886-12574351-545019126-17585451-680020176-27596801-850021276-425108501-1070022426-6251110700×ñÑÉÏÊöµÝ½ø¹æÂÉ ×¢ 1£º±í QMS 1 ÖеÄÈËÊýÒËÊÓΪÁ¬Ðø±ä»¯µÄ£¬¶ø²»Êǽ×ÌÝʽ±ä»¯µÄ¡£ ×¢ 2£ºÈÏÖ¤»ú¹¹µÄ³ÌÐò¿ÉÒԹ涨ÈËÊý³¬¹ý 10700 ÈËʱµÄÉóºËʱ¼ä¡£¸ÃÉóºËʱ¼äÒË×ñѱí QMS 1 Öеĵݽø¹æÂÉ£¬Óë¸Ã±í±£³ÖÒ»Ö¡£
·¢²¼Ê±¼ä:
2018
-
03
-
19
ä¯ÀÀ´ÎÊý£º496
¹ú¼Ê»¯×±Æ·ÔÁÏGMPÖ¸ÄÏ ¡ª EFfCI GMPÌôÕ½»¯×±Æ·ÔÁϵÄÖÊÁ¿¶ÔÓÚ±£Ö¤»¯×±Æ·ºÍÏà¹ØµÄ¸öÈË·À»¤ÓÃÆ·µÄ°²È«¡¢ÖÊÁ¿ºÍ¹¦Ð§ÊÇÖÁ¹ØÖØÒªµÄ¡£»¯×±Æ·ÔÁÏÓÐ×Å·¶Î§¹ã·ºµÄÓÃ;£¬ÊÇ»¯×±Æ·Åä·½µÄÖ÷Òª³É·Ý¡£Òò´Ë£¬Ó¦Óû¯×±Æ·ÔÁÏÊÊÓõÄÁ¼ºÃ²Ù×÷¹æ·¶£¨GMP£©ÊDZز»¿ÉÉٵġ£EFfCI£¨European Federation for Cosmetic Ingredients£©ÊÇÅ·ÖÞ»¯Ñ§ºÍÌìÈ»ÔÁÏÐÐҵлáµÄÓ¢Îļò³Æ£¬ÊÇÅ·ÖÞ»¯×±Æ·ÐÐÒµµÄ¹©Ó¦É̺ͷþÎñÌṩÉÌÁªÃË¡£EFfCIÓÚ2000Äê³ÉÁ¢£¬´ú±íÁËÅ·ÖÞ³¬¹ý100¼Ò»¯×±Æ·ÔÁϹ«Ë¾µÄ¼¯ÌåÀûÒæ¡£Æä³ÉÔ±°üÀ¨BASF¡¢BIOCHIM¡¢CRODA¡¢GATTEFOSSE¡¢RES PHARMA INDUSTRIALE¡¢SABO¡¢VEVY EUROPEµÈÅ·ÖÞ¸÷¹úÖªÃû»¯×±Æ·ÔÁÏÉÌ¡£EFfCI»¯×±Æ·ÔÁÏGMP£¬ÊÇÓÉEFfCI·¢²¼µÄÈÏÖ¤±ê×¼£¬Æä¸ù±¾ÀíÄÊÇΪ»¯×±Æ·ÔÁÏÖÆÔìÉÌÌṩһ¸ö¸üºÏÊʵġ¢ÓбðÓÚ»¯×±Æ·µÄ¡¢¾ßÓпɲÙ×÷ÐÔµÄGMPÖ´Ðй¤¾ß¡£EFfCI·Ç³£ÖØÊÓ×îÐÂÆÀÂÛ£¬ÒÔ×÷ΪEFfCI GMPÖ¸ÄϽøÒ»²½·¢Õ¹µÄÊäÈë¡£×Ô2005Äê³É¹¦ÍÆÐС¢2008Äê¸üÐÂÈÏÖ¤¼Æ»®ºÍ±ê×¼ÒÔÀ´£¬EFfCI:2012 GMPÊÇÓ¡Ë¢·¢ÐеĵÚÈý°æ±ê×¼£¬ÍêÈ«ÕûºÏÁËISO9001:2008±ê×¼µÄÄÚÈÝ£¬ÔÚÈ·±£·´Ó³ISO9001±ê×¼×îа汾ÄÚÈݵÄͬʱ£¬»¹²Î¿¼ÁËÒ©Æ·ºÍʳƷGMPÒªÇ󣬼ÓÈëÁËÖÊÁ¿·çÏÕ¹ÜÀí·½·¨£¬ÒÔ°ïÖú»¯Ñ§ºÏ³ÉºÍÏà¹ØÖÆÔì¹ý³ÌÖ´...
·¢²¼Ê±¼ä:
2017
-
04
-
19
ä¯ÀÀ´ÎÊý£º986